Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Projected Market Size and Growth Rates for the Digital Biomarkers Market From 2025 To 2029?
In recent times, the size of the digital biomarkers market has witnessed exponential growth. The market is set to expand from its 2024 size of $3.92 billion to $4.96 billion in 2025, marking a compound annual growth rate (CAGR) of 26.3%. Factors contributing to this growth in the historical period include the upsurge in mobile health applications, early implementation in clinical trials, increasing chronic disease prevalence, consumer interest in health and wellness, and the rising digitization of the healthcare industry.
What Is the Projected Market Size of the Digital Biomarkers Market?
The market size of digital biomarkers is forecasted to experience substantial growth in the upcoming years, expanding to reach a value of $12.52 billion by 2029 with a compound annual growth rate (CAGR) of 26.1%. The promising growth projection within this timeframe is tied to factors such as the escalating adoption by healthcare providers, continually rising prevalence of chronic diseases, growing comprehension amongst consumers, and increased interest in fitness and lifestyle tracking. Significant trends expected within the period of forecast include advancements in wearable technology, incorporation of artificial intelligence, strategic collaborations and partnerships, expansion in up-and-coming markets, and improved integration with electronic health records.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19397&type=smp
Who are the Major Competitors in the Digital Biomarkers Market Outlook?
Major companies operating in the digital biomarkers market are Pfizer Inc., Bayer AG, F Hoffmann-La Roche Ltd., Eli Lilly and Company, Koninklijke Philips NV (Philips), GE Healthcare, Biogen Inc., Garmin Ltd., Clario, Verily Life Sciences LLC, Altoida Inc., BioSerenity, Oura Health Oy., Evidation Health Inc., AliveCor Inc., Empatica Inc., ActiGraph LLC, VivoSense Inc., BioSensics LLC, Koneksa Health Inc., ATCOR Medical Pty Ltd., Brainomix Limited
What Is Fueling Growth in the Digital Biomarkers Market?
The escalating occurrence of chronic health conditions is set to stimulate the expansion of the digital biomarkers market in the future. Chronic ailments represent long-duration health issues with a gradual progression rate, often persisting for a prolonged period, if not a lifetime. The manifestation of such diseases is heightened with age-specific chronic issues such as osteoarthritis, Alzheimer’s, and heart disease. Factors such as high intake of processed foods and decreased physical mobility further raise the risk of chronic diseases. Digital biomarkers play a key role in these diseases by monitoring health metrics and disease progression in real-time, thereby allowing for tailored and immediate interventions. For instance, as reported by the Centers for Disease Control and Prevention (CDC.gov), a US-based government agency, in May 2023, deaths from heart disease and cancer reached a total of 6,95,547 in 2022, showing a considerable influx from 6,05,213 in 2021. As such, the increasing prevalence of chronic diseases underscores the projected growth of the digital biomarker market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=19397&type=smp
Which Digital Biomarkers Market Segments Are Growing the Fastest?
The digital biomarkersmarket covered in this report is segmented –
1) By Type: Wearable, Mobile Based Applications, Sensors, Other Types
2) By Clinical Practice: Diagnostic Digital Biomarkers, Monitoring Digital Biomarkers, Predictive And Prognostic Digital Biomarkers, Other Clinical Practices
3) By Application: Oncology, Metabolic Disease, Neurological Disease, Cardiac Disease, Other Applications
4) By End User: Healthcare Companies, Healthcare Providers, Payers, Other End Users
Subsegments:
1) By Wearable: Smartwatches, Fitness Trackers, Wearable ECG Monitors, Continuous Glucose Monitors
2) By Mobile Based Applications: Health Monitoring Apps, Digital Therapeutics Apps, Symptom Tracking Apps, Remote Patient Monitoring Apps
3) By Sensors: Biosensors, Motion Sensors, Environmental Sensors, Implantable Sensors
4) By Other Types: Voice Biomarkers, Digital Imaging Biomarkers, Behavioral Biomarkers, Telemedicine Tools
Which Industry Trends Are Shaping the Future of the Digital Biomarkers Market?
In the digital biomarker market, leading companies are broadening their service offerings and extending their horizons by embracing a strategic alliance strategy. Such an alliance is a cooperative link between two or more firms where they amalgamate their knowledge, resources, and endeavor to fulfill shared aims or purposes. As an example, in September 2023, a strategic partnership was established between ProofPilot, an automated clinical trial service from the US, and Eli Lilly and Company, a US-based pharmaceutical firm. Their combined effort aimed at incorporating Lilly’s ground-breaking, patent-pending Magnol.AI sensor cloud platform into the technological repertoire of ProofPilot. This avant-garde platform is known for its exceptional security and manageability of high-frequency sensor data. The purpose of this union is to boost efficient digital health research and expedite pre-competitive biomedical examinations. The merged setup empowers researchers with real-time data science facilities, providing them a deeper comprehension of sensor data. It also aligns with clinician and patient-reported outcomes, thus paving the way forward for advancement in digital health and biomarker studies.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/digital-biomarkers-global-market-report
Which Countries Are Leading the Digital Biomarkers Market?
North America was the largest region in the digital biomarkers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19397
This Report Delivers Insight On:
1. How big is the digital biomarkers market, and how is it changing globally?
2. Who are the major companies in the digital biomarkers market, and how are they performing?
3. What are the key opportunities and risks in the digital biomarkers market right now?
4. Which products or customer segments are growing the most in the digital biomarkers market?
5. What factors are helping or slowing down the growth of the digital biomarkers market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model